About seer inc /ca/ - SEER
Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and software, which provides workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr. and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.
SEER At a Glance
Seer, Inc. (California)
3800 Bridge Parkway
Redwood City, California 94065
| Phone | 1-650-453-0000 | Revenue | 16.12M | |
| Industry | Biotechnology | Net Income | -73,600,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 15.573% | |
| Fiscal Year-end | 12 / 2026 | Employees | 124 | |
| View SEC Filings |
SEER Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 6.522 |
| Price to Book Ratio | 0.397 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.789 |
| Enterprise Value to Sales | -3.543 |
| Total Debt to Enterprise Value | -0.414 |
SEER Efficiency
| Revenue/Employee | 129,991.935 |
| Income Per Employee | -593,548.387 |
| Receivables Turnover | 2.708 |
| Total Asset Turnover | 0.049 |
SEER Liquidity
| Current Ratio | 12.844 |
| Quick Ratio | 12.347 |
| Cash Ratio | 11.847 |
SEER Profitability
| Gross Margin | 11.80 |
| Operating Margin | -486.699 |
| Pretax Margin | -455.357 |
| Net Margin | -456.604 |
| Return on Assets | -22.213 |
| Return on Equity | -25.082 |
| Return on Total Capital | -26.011 |
| Return on Invested Capital | -23.306 |
SEER Capital Structure
| Total Debt to Total Equity | 9.121 |
| Total Debt to Total Capital | 8.359 |
| Total Debt to Total Assets | 7.988 |
| Long-Term Debt to Equity | 8.128 |
| Long-Term Debt to Total Capital | 7.449 |